Posted on 8/13/2025
Platform integrates yeast-based synthetic biology and robotics to streamline antibody discovery, eliminating lengthy steps and significantly reducing costs compared to traditional CRO outsourcing
Opentrons Labworks, Inc., recognized worldwide for accessible lab automation with more than 10,000 robotic systems deployed, and Neochromosome, Inc., its subsidiary specializing in products unlocked through genome-scale cell engineering, today announced the Opentrons Flex® neoSwitch™ Workstation powered by the Neochromosome® neoSwitch platform for in-house antibody disco...